you deserve it. The ignore is a beautiful thing and there are maybe 20 posts/threads here(motley article etc) worth anyone's time.It is a multiyear investment not a race to 3 dollars.I expect INO to go lower because of the momentum players and that is an opinion.I own INO GL
Bakers now own the float.What is different from others they have M&A is the concentrated ownership would allow them to go private which would lower any reg shareholders profit.
31 in a flash in the meantime
See the SEC docs for details and 28 is the bottom as management gives out stock options award and cash reward bonus to upper levelers.Why a co pretends to issue the annual shareholders meeting anouncement 4 months before it is uppossedly to happen is suspicious.Not sure of the outcome but the boys will get theirs.
taking a company private as opposed to a sale to a big pharma will yield much less to shareholders,but the Bakers would make far more money by owning 50% of a private company with a 25 Billion dollar future market.
Buyouts sometimes have low prices,with the avg premium 40%, going private the premium is half that 20%, say $35 a share.Todays news is disappointing to regular shareholders
would anyone take that? which incidentially is the range quoted.I woul - ) but I am new here.
No, because I work in the biocluster area of SD and eat lunch at a popular eatery frequented by the brass.You dont have to believe it, I surely wouldnt bet the farm,but it makes sense.I wasnt all that familiar with Genomic before.
stung by the Complete Genomics fiasco,Illumina is getting ready to make a bid ( initially in the 50-60 range 1.7B range ) for Genomic Health
I looked at it
BS bud Institutions headed for the door . There is few around Thats a FACT.
This si why they cant get a deal - no backing -
There will now be no dilution
Bankruptcy is not bashing but a very real possibility
Suspect it is 1 or 2 spammers
Real DD elsewhere
Yahoo MB is a joke
I believe a dilutive offering is soon